Skip to main content

Day: December 22, 2022

SONAR System Market to Hit USD 3.76 Billion by 2029 | SONAR System Industry Striking Growth in Turkey, India, Israel, Japan, Norway, United States and ROW

Pune, India, Dec. 22, 2022 (GLOBE NEWSWIRE) — The SONAR system market size is predicted to reach USD 3.76 billion by 2029 and exhibit a CAGR of 7.96% during the projected period. Fortune Business Insights has presented this information in its report titled, “SONAR System Market, 2022-2029”. The market stood at USD 2.09 billion in 2021 and USD 2.20 billion in 2022. Sound Navigation and Ranging (SONAR) is a sophisticated technique that uses sound propagation to navigate and communicate with underwater objects. Get a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sonar-system-market-101830 List of Key Market Players:ASELSAN A.Ş. (Turkey) ATLAS ELEKTRONIK INDIA Pvt. Ltd. (India) DSIT Solutions Ltd. (Israel) EdgeTech (U.S.) FURUNO ELECTRIC CO., LTD. (Japan) Japan Radio Co. (Japan) KONGSBERG...

Continue reading

Hummus Market to Reach USD 6.60 Billion by 2028 | Exhibiting a CAGR of 12.17% by 2021-2028

Companies Covered in the hummus market research report are Nestlé S.A. (Vevey, Switzerland), Cedar’s Mediterranean Foods, Inc. (Massachusetts, U.S.), Haliburton International Foods, Inc. (California, U.S.), Strauss Group, Ltd. (Sabra Dipping Company, LLC) (Petah Tikva, Israel), Bakkavor Group Plc (London, United Kingdom), Tribe Hummus (Massachusetts, U.S.), Boar’s Head Brand (Florida, United States), Hummus Gourmet, LLC (Lantana Foods) (Texas, U.S.), The Kraft Heinz Company (Illinois, U.S.), Hope Foods, LLC. (Colorado, U.S.), and more players Pune, India, Dec. 22, 2022 (GLOBE NEWSWIRE) — The global hummus market size is set to gain momentum from the increasing shift of people towards the vegan diet, especially in Europe and North America. The surging awareness of environmental sustainability and animal welfare is compelling people...

Continue reading

Drip Irrigation Market to Hit USD 9.37 Billion by 2026 | With 9.3% CAGR

Companies covered in Drip Irrigation Market are Lindsay Corporation, Jain Irrigation Systems Ltd., Rivulis Irrigation Ltd., Rain Bird Corporation, Sistema Azud, Netafim Limited, The Toro Company, Elgo Irrigation Ltd., Chinadrip Irrigation Equipment Co. Ltd., Metzer Group, Antelco Pty Ltd. and more players. Pune, India, Dec. 22, 2022 (GLOBE NEWSWIRE) — The global drip irrigation market size is projected to reach USD 9.37 billion by the end of 2026. The increasing number of farming activities will bode well for the market in the coming years. According to a report published by Fortune Business Insights, titled “Drip Irrigation Market Size, Share & Industry Analysis, and Regional Forecast, 2019–2026,” the market was worth USD 4.63 billion and will exhibit a CAGR of 9.3% during the forecast period. List of Key Players Covered...

Continue reading

Otonomy Announces Change in Stock Exchange Listing

SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq) indicating that the company’s shares would be suspended from trading on Nasdaq effective at the open of business on December 23, 2022. Following such suspension, the company’s shares will be traded on the OTC Pink Market. As previously reported, on November 14, 2022, Otonomy received a notice from Nasdaq indicating that the Listing Qualifications Staff (the Staff) had determined to delist the company’s securities unless the company timely requested a hearing before the Nasdaq Hearings Panel (the Panel). The Staff’s determination was due to the company’s securities having a closing bid price of less than $0.10 per share for the preceding ten...

Continue reading

China Index Holdings Enters into Definitive Agreement for Going-Private Transaction

BEIJING, Dec. 22, 2022 (GLOBE NEWSWIRE) — China Index Holdings Limited (NASDAQ: CIH), (“CIH” or the “Company”), a leading real estate information and analytics service platform provider in China, today announced that it has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CIH Holdings Limited (“Parent”) and CIH Merger Sub Holdings Limited (“Merger Sub”), a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company, with the Company continuing as the surviving company and becoming a wholly-owned subsidiary of Parent (the “Merger”), in a transaction implying an equity value of the Company of approximately US$92.0 million. At the effective time of the Merger (the “Effective Time”), each American depository...

Continue reading

Microbix Reports Record Sales for Fiscal 2022

Record Sales of $19.1 million, Net Earnings of $1.8 million MISSISSAUGA, Ontario, Dec. 22, 2022 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2022 (“2022” and “Q4”), with record sales and continued positive net earnings, plus ongoing progress upon its strategic goal of increasing its capacity for medical devices production and, over time, to thereby grow sales, margins, and earnings. Management Discussion 2022 sales achieved a new record of $19.1 million as Microbix continues to emphasize operational excellence and increase sales of innovative, proprietary, and branded medical devices. Sales of test quality assessment products (“QAPs™”) and viral transport medium (“DxTM™”)...

Continue reading

Radisson publishes year-end letter

Figure 1. The O’Brien gold project – 5.2km longitudinal sectionROUYN-NORANDA, Quebec, Dec. 22, 2022 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTC: RMRDF) (“Radisson” or the “Company“) and its interim CEO and President are pleased to share some year-ends thoughts. As 2022 nears to an end, I wanted to take this opportunity to share with you a summary of the developments and activities the Radisson Team carried out during the year, as well as highlight some of the milestones we achieved. In June 2022, we completed our largest ever diamond drilling program. The 127,600 meters campaign was initiated in late 2019, a total of 256 holes were drilled. Out of the 246 holes published so far, 85% (208 intercepts) returned assays above 3 g/t Au. Results confirm the very high-grade nature of our gold system and...

Continue reading

Whitestone REIT Adds Lake Woodlands Crossing to its Houston Portfolio

Lake Woodlands Crossing Whitestone REIT Acquires Lake Woodlands CrossingHOUSTON, Dec. 22, 2022 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE:WSR) (“Whitestone” or the “Company”) today announced the acquisition of Lake Woodlands Crossing, a 60,246 square foot retail property in The Woodlands, TX. “This acquisition marks Whitestone’s first acquisition in the Houston market since its acquisition of BLVD Place, a Whole Foods Market anchored property in the Uptown District in 2017, and positions Whitestone to benefit from continued growth in The Woodlands, home to numerous corporate campuses and businesses, including Huntsman Corporation, Halliburton, Baker Hughes, OXY and Woodforest National Bank,” said Whitestone REIT Chief Operating Officer, Christine Mastandrea. “Lake Woodlands Crossing is a high-traffic center and benefits from a...

Continue reading

Affimed Announces Approval of Clinical Trial Application in France for a Phase 1 Study of AFM28 in Relapsed/Refractory Acute Myeloid Leukemia

AFM28 monotherapy receives authorization of a Clinical Trial Application (CTA) for the phase 1 study by the French National Agency for the Safety of Medicines and Health Products (ANSM) Initiation of AFM28 clinical development in the first half of 2023 on trackHEIDELBERG, Germany, Dec. 22, 2022 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that the ANSM has authorized a CTA for the phase 1 study of AFM28 (AFM28-101) in relapsed/refractory acute myeloid leukemia (AML). “The CTA approval in France is an important milestone in our strategy to develop AFM28 as quickly as possible,” said Dr. Wolfgang Fischer, Chief Operating Officer at Affimed. “AML is one of the worst blood...

Continue reading

MT Højgaard Holding A/S: MT Højgaard Holding initiates sales process for Scandi Byg and adjusts 2022 guidance

The board of directors of MT Højgaard Holding has decided to initiate a sales process for Scandi Byg after an extensive strategic review. The process is initiated to focus on the group’s subsidiaries within construction and civil works of which MT Højgaard Holding is the best owner and has the best opportunities to create value. Dialogue has been initiated with potential buyers of Scandi Byg. The sales process will not impact neither existing, planned nor new projects in Scandi Byg. Operations continue unchanged under the new executive management, which took office in November 2022, and with full support from MT Højgaard Holding. As a consequence of the decision, Scandi Byg will not be included in revenue and operating profit in the consolidated financial statements for 2022, but be classified as discontinuing activities. On this background,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.